Nortriptyline mechanism of action
Pro Research Analysisby 
Searched over 200M research papers
Nortriptyline Mechanism of Action: Neurotransmitter Modulation and Receptor Activity
Nortriptyline is a tricyclic antidepressant with several mechanisms contributing to its therapeutic effects. One key action is its ability to block certain serotonin (5-hydroxytryptamine, 5-HT) receptors in the brain. Nortriptyline shows affinity for some serotonin receptor sites and can block behaviors in animals that are dependent on serotonin receptor activity, suggesting that serotonin receptor blockade may play a role in its antidepressant effects .
Nortriptyline and Neuropathic Pain: Role of Adrenoceptors and Opioid Receptors
Nortriptyline is also used to manage neuropathic pain, particularly in diabetic polyneuropathy. Its pain-relieving effects depend on the activation of beta-2 adrenoceptors and delta opioid receptors, but not alpha-2 adrenoceptors or mu opioid receptors. Chronic, but not acute, treatment with nortriptyline alleviates pain, and blocking beta-2 adrenoceptors or delta opioid receptors reverses this effect, highlighting their importance in nortriptyline’s mechanism for pain relief 29.
Anti-Inflammatory Effects: Cytokine Suppression
Nortriptyline reduces the release of pro-inflammatory cytokines such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) in glial and microglial cell cultures. This suppression occurs at drug concentrations achievable in clinical treatment and suggests that nortriptyline’s antidepressant action may involve modulation of the central cytokine network 45. In patients with chronic obstructive pulmonary disease (COPD), nortriptyline also decreases the production of several pro-inflammatory cytokines in immune cells, further supporting its anti-inflammatory properties 68.
Cellular Protection and Mitochondrial Effects
Nortriptyline has been shown to protect brain cells (astrocytes) from damage caused by lack of oxygen and glucose. It does this by reducing the expression of cytosolic phospholipase A2 (cPLA2), which in turn decreases the release of arachidonic acid, a molecule involved in cell damage. Nortriptyline also helps maintain mitochondrial function and prevents cell death in these conditions .
Additional Mechanisms: Oxidative Stress and Apoptosis in Cancer Cells
Beyond its psychiatric and pain applications, nortriptyline has demonstrated anti-cancer effects in laboratory studies. It induces oxidative stress and activates the Keap1-Nrf2 pathway, leading to increased cell death in gastric and bladder cancer cells. Nortriptyline triggers both intrinsic (mitochondria-mediated) and extrinsic (death receptor-mediated) apoptosis, and these effects are associated with increased production of reactive oxygen species (ROS) 710.
Conclusion
Nortriptyline’s mechanism of action is multifaceted. It involves serotonin receptor blockade, modulation of adrenoceptors and opioid receptors for pain relief, suppression of pro-inflammatory cytokines, protection of brain cells through mitochondrial stabilization, and induction of oxidative stress and apoptosis in cancer cells. These diverse actions contribute to its effectiveness in treating depression, neuropathic pain, and potentially other conditions.
Sources and full results
Most relevant research papers on this topic
The antiallodynic action of nortriptyline and terbutaline is mediated by β(2) adrenoceptors and δ opioid receptors in the ob/ob model of diabetic polyneuropathy.
Chronic treatment with nortriptyline and terbutaline alleviates diabetic neuropathy-induced neuropathic pain, mediated by 2 adrenoceptors and opioid receptors.
Cytosolic phospholipase A₂ inhibition is involved in the protective effect of nortriptyline in primary astrocyte cultures exposed to combined oxygen-glucose deprivation.
Nortriptyline protects ischemic astrocytes by attenuating cPLA2 expression and inhibiting arachidonic acid release, potentially benefiting brain health in ischemia-related conditions.
Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures.
Amitriptyline and nortriptyline reduce pro-inflammatory cytokine release in rat mixed glial and microglial cell cultures, suggesting a central mechanism of action for these drugs in depression.
Amitriptyline and nortriptyline inhibit interleukin-1 b and tumour necrosis factor- a release by rat mixed glial and microglial cell cultures
Amitriptyline and nortriptyline reduce pro-inflammatory cytokine release in rat mixed glial and microglial cell cultures, suggesting a central mechanism of action for these drugs.
Nortriptyline enhances corticosteroid sensitivity of blood T cells from patients with chronic obstructive pulmonary disease.
Nortriptyline alone has anti-inflammatory effects on COPD patients' blood cells, and when combined with corticosteroids, they show synergistic anti-inflammatory effects.
DOI